Prolongation of mouse skin allograft survival by treatment with cytosine arabinoside in combination with F 1  hybrid lymphocytes.
D000818:Animals; D001803:Blood Transfusion; D003433:Crosses, Genetic; D003561:Cytarabine / Q000627:therapeutic use*; D004247:DNA / Q000037:antagonists & inhibitors; D005260:Female; D006648:Histocompatibility; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D016038:Skin Transplantation; D013997:Time Factors; D014019:Tissue Donors; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D003561:Cytarabine; D004247:DNA